SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-123362
Filing Date
2016-09-09
Accepted
2016-09-09 14:04:02
Documents
2
Period of Report
2016-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v448583_6k.htm 6-K 10155
2 MATERIAL CHANGE REPORT FILED SEPTEMBER 9, 2016. v448583_ex99-1.htm EX-99.1 20229
  Complete submission text file 0001144204-16-123362.txt   31388
Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7
Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770
Transition Therapeutics Inc. (Filer) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-33514 | Film No.: 161878543
SIC: 2833 Medicinal Chemicals & Botanical Products